Lava Therapeutics NV (LVTX) PT Lowered to $1 at Leerink Partners, 'We remain cautious'
Tweet Send to a Friend
Leerink Partners analyst Daina Graybosch lowered the price target on Lava Therapeutics NV (NASDAQ: LVTX) to $1.00 (from $2.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
